We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





Erba Unveils New H 7100 Advanced Hematology Analyzer

By LabMedica International staff writers
Posted on 05 Feb 2025

ERBA Mannheim (Mannheim, Germany) has unveiled the new H 7100 advanced hematology analyzer that is designed to redefine hematology analysis. More...

This state-of-the-art diagnostic instrument promises a paradigm shift in blood analysis capabilities, catering to the complex needs of clinical laboratories and research facilities.

Hematology analyzers are revolutionizing modern clinical labs, delivering crucial insights into blood composition for diagnosing and monitoring various disorders. With technological advancements, these tools now offer enhanced performance, accuracy, and efficiency. The H 7100 is a breakthrough in hematology diagnostics, redefining the field by enabling rapid, reliable insights for clinicians and enhancing diagnostic accuracy and research capabilities. Equipped with fluorescence flow cytometry technology, the H 7100 has a 70-parameter range including Reticulocytes, Immature Platelet Fraction (IPF) and Immature Granulocytes (IG). These are critical for diagnosing, monitoring and treating conditions like anemia, thrombocytopenia, infection, inflammation and myeloid neoplasms. It offers real-time insights of response to allergic leukemia, anemia, bone marrow failure syndromes and hemolytic disorders.

With its advanced algorithms improving clinical decision-making and patient care, the H 7100 redefines the hematology diagnostics space by enabling rapid, reliable insights for clinicians and enhancing diagnostic accuracy and research capabilities in the field. The H7100 sets itself apart with a throughput of 90 tests per hour for CBC+diff and 70 tests per hour for CBC+Diff+retics. Fully automated, it can become a 2X system by adding additional units and samplers. Its Mentzer Index feature helps differentiate between Iron Deficiency Anemia (IDA) and Beta Thalassemia while its Optical Platelet (Plt-O) feature addresses challenges like pseudo-thrombocytopenia in hematological analysis. Optical platelet count reduces the spurious count and is useful in correcting spurious low platelet counts in EDTA-PTCP patients. Cost-effective and minimizing reagent usage, the H7100 is ideal for large and medium-sized labs, corporate hospitals, and B2B labs.


Gold Member
Respiratory Syncytial Virus Test
OSOM® RSV Test
Portable Electronic Pipette
Mini 96
Gel Cards
DG Gel Cards
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New evidence shows viscoelastic testing can improve assessment of blood clotting during postpartum hemorrhage (Photo courtesy of 123RF)

Viscoelastic Testing Could Improve Treatment of Maternal Hemorrhage

Postpartum hemorrhage, severe bleeding after childbirth, remains one of the leading causes of maternal mortality worldwide, yet many of these deaths are preventable. Standard care can be hindered by delays... Read more

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: The enhanced collaboration builds upon the successful launch of the AmplideX Nanopore Carrier Plus Kit in March 2025 (Photo courtesy of Bio-Techne)

Bio-Techne and Oxford Nanopore to Accelerate Development of Genetics Portfolio

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded its agreement with Oxford Nanopore Technologies (Oxford, UK) to broaden Bio-Techne's ability to develop a portfolio of genetic products on Oxford... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.